14550809

Source:http://linkedlifedata.com/resource/pubmed/id/14550809

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013018, umls-concept:C0018939, umls-concept:C0030705, umls-concept:C0037047, umls-concept:C0043162, umls-concept:C0059985, umls-concept:C0205197, umls-concept:C0205263, umls-concept:C0205329, umls-concept:C0206153, umls-concept:C0301944, umls-concept:C0332283, umls-concept:C1527169, umls-concept:C2323499
pubmed:issue	10
pubmed:dateCreated	2003-10-10
pubmed:abstractText	The aim of this study was to determine whether nonmyeloablative transplants (NMT) result in complete and sustained donor engraftment in patients with progressive hematologic diseases compared to patients with stable disease or who are in remission.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0402313
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclosporine, http://linkedlifedata.com/resource/pubmed/chemical/Vidarabine, http://linkedlifedata.com/resource/pubmed/chemical/fludarabine
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0301-472X
pubmed:author	pubmed-author:AymerichMartaM, pubmed-author:CarrerasEnricE, pubmed-author:Fernández-AvilésFrancescF, pubmed-author:JiménezMónicaM, pubmed-author:MartínezCarmenC, pubmed-author:MontserratEmiliE, pubmed-author:RoviraMontserratM, pubmed-author:TalarnCarmeC, pubmed-author:Urbano-IspizuaAlvaroA
pubmed:issnType	Print
pubmed:volume	31
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	934-40
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:14550809-Adult, pubmed-meshheading:14550809-Aged, pubmed-meshheading:14550809-Cyclosporine, pubmed-meshheading:14550809-Female, pubmed-meshheading:14550809-Graft vs Host Disease, pubmed-meshheading:14550809-Graft vs Leukemia Effect, pubmed-meshheading:14550809-Hematologic Diseases, pubmed-meshheading:14550809-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:14550809-Histocompatibility Testing, pubmed-meshheading:14550809-Humans, pubmed-meshheading:14550809-Male, pubmed-meshheading:14550809-Middle Aged, pubmed-meshheading:14550809-Myeloid Cells, pubmed-meshheading:14550809-Prospective Studies, pubmed-meshheading:14550809-T-Lymphocytes, pubmed-meshheading:14550809-Tissue Donors, pubmed-meshheading:14550809-Transplantation Chimera, pubmed-meshheading:14550809-Transplantation Conditioning, pubmed-meshheading:14550809-Vidarabine, pubmed-meshheading:14550809-Whole-Body Irradiation
pubmed:year	2003
pubmed:articleTitle	Low-dose total-body irradiation and fludarabine followed by hematopoietic cell transplantation from HLA-identical sibling donors do not induce complete T-cell donor engraftment in most patients with progressive hematologic diseases.
pubmed:affiliation	Institute of Hematology and Oncology, IDIBAPS, Postgraduate School of Hematology Farreras Valentí, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't